FDA NDC Directory · JSON-LD · Markdown

CABOMETYX

NDC 42388-025 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namecabozantinib
Labeler / ManufacturerExelixis, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208692
Dosage form / routeTABLET · ORAL
Active ingredientsCABOZANTINIB S-MALATE (40 mg/1)
Marketing started20160425
Package count4

External sources

Source: openFDA. Public-domain (CC0).